Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Biotech
Sanofi nails phase 3 LUNA landing, sparking race to regulators
Sanofi plans to file for approval of a “multi-indication blockbuster” that it predicts could contribute to more than 10 billion euros of launch sales.
Nick Paul Taylor
Apr 23, 2024 2:23am
Sanofi cuts staff in Belgium as early-stage research dwindles
Apr 19, 2024 11:34am
Sanofi shrinks $6B biobucks deal with IGM
Apr 17, 2024 11:05am
Synthekine hopes new IL-2 will be the high-alpha in a beta class
Apr 10, 2024 9:50am
Sanofi axes jobs, research after 'full pipeline' shakeup
Apr 5, 2024 10:53am
Top 10 pharma R&D budgets in 2023
Mar 18, 2024 5:00am